James Mazzo: Growing A Goliath With A Small Company Mentality
Executive Summary
Having worked in the ophthalmic device industry for more than 35 years in both multinationals and start-ups, James Mazzo’s latest port of call is at Carl Zeiss Meditec as head of the group’s ophthalmology business. He discusses with Medtech Insight what he views to be the strengths and weaknesses of the global business, which he says has the broadest product offering in the ophthalmic industry, and how he plans to help a market giant grow even bigger.
You may also be interested in...
Carl Zeiss Hires CMO To Link Up With Eyecare KOLs
Carl Zeiss Meditec has hired a new chief medical officer for its global ophthalmic business.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.